BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34135394)

  • 1. Mutant p53s and chromosome 19 microRNA cluster overexpression regulate cancer testis antigen expression and cellular transformation in hepatocellular carcinoma.
    Jinesh GG; Napoli M; Smallin MT; Davis A; Ackerman HD; Raulji P; Montey N; Flores ER; Brohl AS
    Sci Rep; 2021 Jun; 11(1):12673. PubMed ID: 34135394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of MYO18B mRNA by a network of C19MC miRNA-520G, IFN-γ, CEBPB, p53 and bFGF in hepatocellular carcinoma.
    Jinesh GG; Napoli M; Ackerman HD; Raulji PM; Montey N; Flores ER; Brohl AS
    Sci Rep; 2020 Jul; 10(1):12371. PubMed ID: 32704163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.
    Augello C; Colombo F; Terrasi A; Trombetta E; Maggioni M; Porretti L; Rossi G; Guerneri S; Silipigni R; Bosari S; Vaira V
    Dig Liver Dis; 2018 Jun; 50(6):583-593. PubMed ID: 29673952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
    Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
    Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss.
    Setty BA; Jinesh GG; Arnold M; Pettersson F; Cheng CH; Cen L; Yoder SJ; Teer JK; Flores ER; Reed DR; Brohl AS
    PLoS Genet; 2020 Apr; 16(4):e1008642. PubMed ID: 32310940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated expression of clustered cancer/testis genes encoded in a large inverted repeat DNA structure.
    Bredenbeck A; Hollstein VM; Trefzer U; Sterry W; Walden P; Losch FO
    Gene; 2008 May; 415(1-2):68-73. PubMed ID: 18395366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma.
    Augello C; Vaira V; Caruso L; Destro A; Maggioni M; Park YN; Montorsi M; Santambrogio R; Roncalli M; Bosari S
    Liver Int; 2012 May; 32(5):772-82. PubMed ID: 22429613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway.
    Guo JC; Yang YJ; Zhang JQ; Guo M; Xiang L; Yu SF; Ping H; Zhuo L
    J Cell Physiol; 2019 Dec; 234(12):23461-23474. PubMed ID: 31232474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis.
    Wang C; Kang H; Yi Y; Ding Y; Wang F; Luo J; Ye M; Hong Y; Xia C; Yan J; Liu L; Liu J; Zhong Z; Zhang Z; Zhao Q; Chang Y
    J Transl Med; 2023 Dec; 21(1):919. PubMed ID: 38110956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
    Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
    J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma.
    Rui T; Xu S; Zhang X; Huang H; Feng S; Zhan S; Xie H; Zhou L; Ling Q; Zheng S
    J Cell Physiol; 2020 Sep; 235(9):6103-6112. PubMed ID: 31975381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.
    Zhang Q; Cao LY; Cheng SJ; Zhang AM; Jin XS; Li Y
    Oncol Rep; 2015 Mar; 33(3):1335-41. PubMed ID: 25591821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long noncoding RNA
    Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
    J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling.
    Yang G; Fu Y; Lu X; Wang M; Dong H; Li Q
    Int J Oncol; 2019 Jan; 54(1):177-187. PubMed ID: 30387834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.
    Lupini L; Pepe F; Ferracin M; Braconi C; Callegari E; Pagotto S; Spizzo R; Zagatti B; Lanuti P; Fornari F; Ghasemi R; Mariani-Costantini R; Bolondi L; Gramantieri L; Calin GA; Sabbioni S; Visone R; Veronese A; Negrini M
    Oncotarget; 2016 May; 7(21):31361-71. PubMed ID: 27120784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer.
    Zhang Y; Geng L; Talmon G; Wang J
    J Biol Chem; 2015 Mar; 290(10):6215-25. PubMed ID: 25616665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.
    Kan H; Guo W; Huang Y; Liu D
    FEBS Lett; 2015 Jan; 589(1):102-9. PubMed ID: 25436421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
    Jang JY; Lee YS; Jeon YK; Lee K; Jang JJ; Kim CW
    Exp Mol Med; 2013 Jan; 45(1):e3. PubMed ID: 23306701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.